COLL
Collegium Pharmaceutical Inc
NASDAQ: COLL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$35.81
+2.11% today
Updated 2026-06-05
Market cap
$1.03B
P/E ratio
15.43
P/S ratio
1.36x
EPS (TTM)
$2.06
Dividend yield
—
52W range
$29 – $51
Volume
0.5M
Collegium Pharmaceutical Inc (COLL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$35.81
12-Month target
$41.56
2030 Target
—
Intrinsic (DCF)
$387.82
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.3B | $0.5B | $0.6B | $0.6B | $0.8B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 15.43x (capped 25x) · Margin: 9.41%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.